Here’s what you need to know:
1. The conference will host 100 participants, including researchers, patient advocacy groups and FDA representatives for discussions on drug development for upper GI disorders.
2. AGA’s goals for the conference include increasing knowledge of clinical, regulatory and scientific challenges in drug development and facilitating therapeutic and diagnostic intervention partnerships.
3. Sessions at the conference focus on topics like gastroesophageal reflux disease, eosinophilic esophagitis, gastroparesis and functional dyspepsia.
More articles on gastroenterology and endoscopy:
Intestinal metabolome analysis may lead to preventative IBD treatment: 5 study insights
IBD patients report high annual salary, educational attainment: 4 study insights
Pure-Vu System effective for intra-procedural colon cleaning: 3 data insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.